119 related articles for article (PubMed ID: 13904049)
1. [Treatment of coronary circulatory disorders in internal practice with segontin].
HAMANN E
Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
[No Abstract] [Full Text] [Related]
2. [Experiences with segontin in internal medical practice].
MENZEL M
Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
[No Abstract] [Full Text] [Related]
3. [A double-blind experiment with the coronary therapeutic agent segontin].
OVERKAMP H
Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518
[No Abstract] [Full Text] [Related]
4. [Experiences with the clinical use of Segontin in coronary disease].
OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with segontin].
RATSCHOW M; SCHOOP W
Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
[No Abstract] [Full Text] [Related]
6. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
DELLA PORTA P; LUCCHINI CR
Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
[No Abstract] [Full Text] [Related]
7. [On new possibilities in the therapy of coronary circulation disorders].
LAUENROTH G
Bull Off Chambre Synd Med Seine; 1960 Aug; 55():1434-5. PubMed ID: 13759428
[No Abstract] [Full Text] [Related]
8. [A contribution to the therapy of coronary circulatory disorders].
BAMBOR HJ
Med Klin; 1960 Jun; 55():1155-61. PubMed ID: 13796348
[No Abstract] [Full Text] [Related]
9. The clinical effects of a new anti-anginal agent, prenylamine ("Segontin").
BAUMGARTEN A
Med J Aust; 1962 Mar; 49(1)():429-31. PubMed ID: 13865947
[No Abstract] [Full Text] [Related]
10. [The use of a pyrimido-pyrimidine derivative as coronary vasodilator in clinical practice].
BENITO SENDIN M; ALVAREZ SANCHEZ E
Medicina (Madr); 1961 Oct; 29():469-82. PubMed ID: 13867248
[No Abstract] [Full Text] [Related]
11. [The treatment of coronary infarct with high doses of 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride as well as the use of vasodilator substances in acute coronary occlusion].
VOELKER R
Arzneimittelforschung; 1962 Mar; 12():299-302. PubMed ID: 13926394
[No Abstract] [Full Text] [Related]
12. [Clinical results with a new coronary dilatator agent: persantin].
MARTINEZ RAMON E; ALCALA LLORENTE E
Med Esp; 1961 Jun; 45():470-87. PubMed ID: 13767501
[No Abstract] [Full Text] [Related]
13. [Observations on a new synthetic coronary vasodilator].
TRALDI A; TINCANI GP
Minerva Med; 1962 Jun; 53():1747-50. PubMed ID: 13922271
[No Abstract] [Full Text] [Related]
14. [Experiences with segontin with special reference to chronic pulmonary heart disease, intrapleural pneumothorax and pneumoperitoneum].
KOLLOTZEK H
Med Welt; 1961 Nov; 44():2305-7. PubMed ID: 14458041
[No Abstract] [Full Text] [Related]
15. [On the therapy of coronary insufficiency].
DUETSCH L
Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
[No Abstract] [Full Text] [Related]
16. [Criteria of the efficacy of the treatment of coronary disease: "the coronary vasodilators"].
CLOAREC M
Sem Hop Ther Paris; 1961 Oct; 37():753-4. PubMed ID: 13879970
[No Abstract] [Full Text] [Related]
17. [A contribution to the therapy of coronary insufficiency].
LEIMGARDT H
Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
[No Abstract] [Full Text] [Related]
18. [Treatment of coronary insufficiency with Persantin].
RIEGLER E
Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
[No Abstract] [Full Text] [Related]
19. [Preliminary results in the treatment of coronary disease with segotonin].
NEDELJKOVIC S; DORDEVIC BS
Med Glas; 1961; 15():400-2. PubMed ID: 14478728
[No Abstract] [Full Text] [Related]
20. [Clinical study of a synthetic coronary vasodilator, L 2329].
JORIS H; SCHMETZ J
Rev Med Liege; 1961 Sep; 16():486-9. PubMed ID: 13790720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
